The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.
Big data in IBD: a look into the future
Open accessAbstract
Big data methodologies, made possible with the increasing generation and availability of digital data and enhanced analytical capabilities, have produced new insights to improve outcomes in many disciplines. Application of big data in the health-care sector is in its early stages, although the potential for leveraging underutilized data to gain a better understanding of disease and improve quality of care is enormous. Owing to the intrinsic characteristics of inflammatory bowel disease (IBD) and the management dilemmas that it imposes, the implementation of big data research strategies not only can complement current research efforts but also could represent the only way to disentangle the complexity of the disease. In this Review, we explore important potential applications of big data in IBD research, including predictive models of disease course and response to therapy, characterization of disease heterogeneity, drug safety and development, precision medicine and cost-effectiveness of care. We also discuss the strengths and limitations of potential data sources that big data analytics could draw from in the field of IBD, including electronic health records, clinical trial data, e-health applications and genomic, transcriptomic, proteomic, metabolomic and microbiomic data. In this Review, the authors explore potential applications of big data in IBD research, including predictive models of disease course and response to therapy, characterization of disease heterogeneity, drug safety and development, precision medicine and cost-effectiveness of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, Rath et al. employed molecular imaging to detect α4β7 integrin expression in a cohort of 5 CD patients before vedolizumab therapy.81”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [81]
In the citing paper
“Their findings revealed that responders to treatment had peri cryptal α4β7+ cells, whereas non-responders did not have any α4β7+ cells.”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
(2011) · Cited by 5,203
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
The Danish National Patient Registry: a review of content, data quality, and research potential
Schmidt, M., Schmidt, S. A. J., Sandegaard, J. L., Ehrenstein, V., Pedersen, L. H., & Sørensen, H. T. (2015) · Clinical Epidemiology · doi:10.2147/clep.s91125 · Cited by 4,832
Detecting influenza epidemics using search engine query data
Ginsberg, J., Mohebbi, M. H., Patel, R. S., Brammer, L., Smolinski, M. S., & Brilliant, L. (2009) · Nature · doi:10.1038/nature07634 · Cited by 4,295
Ungaro, R. C., Mehandru, S., Allen, P. B., Peyrin‐Biroulet, L., & Colombel, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,659
Self-citationPredicting the future - big data, machine learning, and clinical medicine
Obermeyer, Z., & Emanuel, E. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1606181 · Cited by 3,652
Data-intensive applications, challenges, techniques and technologies: A survey on Big Data
Philip Chen, C. L., & Zhang, C.-Y. (2014) · Information Sciences · doi:10.1016/j.ins.2014.01.015 · Cited by 3,047
Big data analytics in healthcare: promise and potential
Raghupathi, W., & Raghupathi, V. (2014) · Health Information Science and Systems · doi:10.1186/2047-2501-2-3 · Cited by 3,034
Research works printed but not linked: 3
- Celgene. Celgene provides update on GED-0301 (mongersen) inflammatory bowel disease program. Celgene https://ir.celgene.com/press-releases/press-release-details/2017/Celgene-Provides-Update-on-GED-0301-mongersen-Inflammatory-Bowel-Disease-Program/default.aspx (2017).
- Boelle, P.-Y., Thiébaut, R. & Costagliola, D. Données massives, vous avez dit données massives? Quest. Santé Publique 30, 1–4 (2015).
- Mirkov, M. U., Verstockt, B. & Cleynen, I. Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol. Hepatol. 2, 224–234 (2017).
Cited by
Sorted by citations
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 993
Gut microbiome, big data and machine learning to promote precision medicine for cancer
Cammarota, G., Ianiro, G., Ahern, A., Carbone, C., Temko, A., Claesson, M. J., Gasbarrini, A., & Tortora, G. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0327-3 · Cited by 324
Artificial intelligence in gastroenterology: A state-of-the-art review
Kröner, P. T., Engels, M. M. L., Glicksberg, B. S., Johnson, K. W., Mzaik, O., van Hooft, J. E., Wallace, M. B., El‐Serag, H. B., & Krittanawong, C. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6794 · Cited by 175
Liang, L., Yang, C., Liu, L., Mai, G., Li, H., Wu, L., Jin, M., & Chen, Y. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01812-6 · Cited by 104
Precision medicine in inflammatory bowel disease: concept, progress and challenges
Borg‐Bartolo, S., Boyapati, R. K., Satsangi, J., & Kalla, R. (2020) · F1000Research · doi:10.12688/f1000research.20928.1 · Cited by 92
Sabater, C., Molina‐Tijeras, J. A., Vezza, T., Corzo, N., Montilla, A., & Utrilla, P. (2019) · Food & Function · doi:10.1039/c9fo02221j · Cited by 86
Ko, Y., Paramsothy, S., Yau, Y. Y., & Leong, R. W. L. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16436 · Cited by 83
Big Data in sleep apnoea: Opportunities and challenges
Pépin, J., Bailly, S., & Tamisier, R. (2019) · Respirology · doi:10.1111/resp.13669 · Cited by 84
Alshehri, D., Saadah, O. I., Mosli, M. H., Edris, S., Al-Hindi, R. R., & Bahieldin, A. (2020) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2020.5016 · Cited by 82
“mation, especially in patients with confirmed IBD [5].”
BackgroundNadalian, B., Yadegar, A., Houri, H., Olfatifar, M., Shahrokh, S., Aghdaei, H. A., Suzuki, H., & Zali, M. R. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15260 · Cited by 75
Nguyen, N. H., Martinez, I., Atreja, A., Sitapati, A. M., Sandborn, W. J., Lucila Ohno-machado, A., & Singh, S. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001545 · Cited by 74
“With the rapid technological advances, digital health tools and telemedicine (defined as diagnosis, treatment, and monitoring of disease by means of the internet, mobile phone applications, and wearable devices) can potentially provide an opportunity for highvalue care by improving efficiency in health care delivery (…”
BackgroundIacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Self-citationBiological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
Song, Y., Zhao, Y., Ma, Y., Wang, Z., Rong, L., Wang, B., & Zhang, N. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.003 · Cited by 73
A systematic review of emerging information technologies for sustainable data-centric health-care
Zahid, A., Poulsen, J. K., Sharma, R., & Wingreen, S. C. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104420 · Cited by 67
Head-to-head trials in inflammatory bowel disease: past, present and future
Pouillon, L., Travis, S. P. L., Bossuyt, P. J., Danese, S., & Peyrin‐Biroulet, L. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0293-9 · Cited by 61
Self-citationNguyen, N. H., Picetti, D., Dulai, P. S., Jairath, V., Sandborn, W. J., Lucila Ohno-machado, A., Chen, P. L., & Singh, S. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab155 · Cited by 62
Li, J., Luo, T., Wang, D., Zhao, Y., Jin, Y., Yang, G., & Zhang, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.035 · Cited by 65
Application of Big Data analysis in gastrointestinal research
Cheung, K. S., Leung, W. K., & Seto, W. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.2990 · Cited by 53
A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease
Yang, L. W., Luo, H., Tan, D., Zhang, S., Zhong, Z., Wang, S., Vong, C. T., & Wang, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153709 · Cited by 51
Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review
Appiah, J. K., Hayat, U., Garg, N., Asante, R., Donneyong, E., Haider, M. U., Patel, P., Khan, Z. H., & Siddiqui, A. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176119 · Cited by 50
“Recent meta-analyses have supported the efficacy and safety of JAK inhibitors in clinical and endoscopic remission [50,51].”
Little, R. D., Jayawardana, T. C., Koentgen, S., Zhang, F., Connor, S. J., Boussioutas, A., Ward, M. G., Gibson, P. R., Sparrow, M., & Hold, G. L. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100006 · Cited by 42
“71 79 This comprehensive narrative review will summarise our current understanding of the genetic, immunological and microbial drivers of IBD.”
BackgroundSerum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease
Shao, J., Jin, Y., Shao, C., Fan, H., Wang, X., & Yang, G. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00280-x · Cited by 42
“Previous reports have shown that numerous factors, such as environment, genes, diet, and microbiota, interact in an intricate way, leading to the biological complexity of IBD [4].”
BackgroundBarco, T. L., Kuchenbuch, M., Garcelon, N., Neuraz, A., & Nabbout, R. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01936-9 · Cited by 43
Liu, C., Yu, R., Zhang, J., Wei, S., Xue, F., Guo, Y., He, P., Shang, L., & Dong, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.972079 · Cited by 37
Ahmad, H. A., East, J. E., Panaccione, R., Travis, S., Canavan, J. B., Usiskin, K., & Byrne, M. F. (2023) · Intestinal Research · doi:10.5217/ir.2023.00020 · Cited by 37
“The integration of omics data into clinical practice using AI can provide personalized medicine in real time to improve quality of care and patient outcomes.(10,43) A machine-learning model predicted endoscopic response to ustekinumab in patients with CD by integrating genomics and transcriptomics data.”
MethodLiang, Q.-H., Li, Q.-R., Chen, Z., Lv, L., Lin, Y., Jiang, H.-L., Wang, K., Xiao, M.-Y., Kang, N.-X., Tu, P., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01840-x · Cited by 35
“Inflammatory bowel disease (IBD) is a group of chronic nonspecific intestinal inflammatory diseases with unknown etiology, including ulcerative colitis (UC) and crohn's disease (CD) [1].”
The burden of cost in inflammatory bowel disease: a medical economic perspective
Beard, J. A., & Click, B. H. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000642 · Cited by 34
“Applications for data aggregation and analysis are being used to developed predictive models of disease course, response to drug therapy, drug safety profiles, understand disease heterogeneity, and evaluate decision models for cost-effectiveness [37].”
MethodImmunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
Selin, K., Hedin, C. R. H., & Villablanca, E. J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab085 · Cited by 36
Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics
Khatab, Z., & Yousef, G. M. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1943302 · Cited by 40
“In recent years, we have seen many success stories of artificial intelligence-based tools applied to big data that can be used to improve public health management and assist decision-making in health care [55,62,63].”
BackgroundZand, A., Stokes, Z., Sharma, A., van Deen, W. K., & Hommes, D. W. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07506-8 · Cited by 33
“There is consensus in the literature that these are negative outcomes for IBD that should be avoided [5, 6].”
BackgroundWhat’s new in IBD therapy: An “omics network” approach
Fiocchi, C., & Iliopoulos, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104886 · Cited by 34
Deng, Z., Zheng, L., Xie, X., Wei, H., & Peng, J. (2020) · The FASEB Journal · doi:10.1096/fj.202000391rr · Cited by 31
Li, P., Wang, Y., Luo, J. F., Zeng, Q., Wang, M., Bai, M., Zhou, H., Wang, J., & Jiang, H. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114115 · Cited by 30
Duan, C., Tang, X., Wang, W., Qian, W., Fu, X., Deng, X., Zhou, S., Han, C., & Hou, X. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4780 · Cited by 30
“Multiple factors, such as genes, diet, environment and the microbiota contribute to complex etiologies (2).”
Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review
Zeng, T., Yu, X., & Chen, Z. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15503 · Cited by 30
“12,18,19 Next, different analysis models and methods could be adopted for the heterogeneous data in gastrointestinal disease research.”
BackgroundMethodGuez, I., Focht, G., Greer, M. C., Cytter-Kuint, R., Pratt, L., Castro, D. A., Turner, D., Griffiths, A. M., & Freiman, M. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107207 · Cited by 29
“In contrast, non-linear machine learning (ML) models demonstrated their potential in leveraging complex non-linear correlations between the input variables and outcomes [23, 24, 25].”
BackgroundEgwuonwu, A., Mendy, J., Oruh, E. S., & Egwuonwu, A. (2024) · IEEE Transactions on Engineering Management · doi:10.1109/tem.2023.3321426 · Cited by 35
“Despite these benefits/successes, it is also opined that most businesses are yet to capitalize on what the utilitarian benefits-discourse of BDA [87].”
BackgroundNutraceuticals for the Treatment of IBD: Current Progress and Future Directions
Ban, Q.-Y., Liu, M., Ding, N., Chen, Y., Lin, Q., Zha, J., & He, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.794169 · Cited by 26
“Interestingly, this disease, which only occurred in developed countries in the past, has increased rapidly in recent years in developing countries that have experienced changes in westernized lifestyles (6, 7).”
BackgroundPark, B., Hwang, Y., Kwon, O., Hwang, S., Lee, J. A., Choi, D.-H., Lee, S., Kim, A. R., Cho, B., Kwon, J., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c14080 · Cited by 26
Mueller-Breckenridge, A. J., García-Alcalde, F., Wildum, S., Smits, S. L., de Man, R. A., van Campenhout, M. J. H., Brouwer, W. P., Niu, J., Young, J. A. T., Nájera, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55445-8 · Cited by 26
“The use of big data advanced analytics is an emergent field with potential for extensive application in health-care 32,33 including applications where there is disease and treatment heterogeneity and for prescriptive analytics (precision medicine and clinical decision support).”
BackgroundVizirianakis, I. S., Miliotou, Α. N., Mystridis, G. A., Andriotis, E. G., Andreadis, I. I., Papadopoulou, L. C., & Fatouros, D. G. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1605828 · Cited by 25
Deng, Z., Liu, Q., Wang, M., Wei, H.-K., & Peng, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4964202 · Cited by 25
“In fl ammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn ’ s disease (CD), is a chronic and relapsing in fl ammatory condition of the gastrointestinal tract, resulting in weight loss, diarrhea, rectal bleeding, and abdominal pain [1 – 3].”
Liu, Z., Bai, P., Wang, L., Zhu, L., Zhu, Z., & Jiang, L. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03486 · Cited by 24
Zhang, W., Chen, X., & Wong, K. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15500 · Cited by 25
“44 Recently, they are also using machine learning technologies to improve the diagnostic performance, lower the cost, and save time.”
BackgroundKatkar, G. D., Sayed, I. M., Anandachar, M. S., Castillo, V., Vidales, E., Toobian, D., Usmani, F., Sawires, J. R., Leriche, G., Yang, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03168-4 · Cited by 24
“4, 5).”
BackgroundZhou, J., Li, C., Lu, M., Jiang, G., Chen, S., Li, H., & Lu, K. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002537 · Cited by 23
Cohen‐Mekelburg, S., Berry, S. K., Stidham, R. W., Zhu, J., & Waljee, A. K. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15405 · Cited by 22
Guo, H., Xie, W., Ji, Z., Wang, B., Ren, W., Gao, W., & Yuan, B. (2024) · Nutrients · doi:10.3390/nu16111591 · Cited by 21
“The common chronic inflammatory illness ulcerative colitis (UC) is characterized by weight loss, diarrhea, and rectal bleeding [1,2].”
BackgroundSchwartzberg, D. M., & Remzi, F. H. (2019) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2019.02.012 · Cited by 22
The role of alcohol dehydrogenase 1C in regulating inflammatory responses in ulcerative colitis
Song, F., Zhang, Y., Pan, Z., Hu, X., Zhang, Q., Huang, F., Ye, X., & Huang, P. C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114691 · Cited by 20
Barco, T. L., Garcelon, N., Neuraz, A., & Nabbout, R. (2023) · Epilepsia · doi:10.1111/epi.17855 · Cited by 19
IBD Systems Biology Is Here to Stay
Fiocchi, C., & Iliopoulos, D. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa343 · Cited by 21
Montoto, C., Gisbert, J. P., Guerra, I., Plaza, R., Pajares, R., Almazán, L. M., Martín, M. D. C. L., Antonaya, M. D., Mendoza, I. V., Aparicio, J., et al. (2022) · JMIR Medical Informatics · doi:10.2196/30345 · Cited by 21
Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease
Thomas, J. P., Módos, D., Korcsmáros, T., & Brooks-Warburton, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760501 · Cited by 21
“This has been lacking in many previous studies (Olivera et al., 2019).”
BackgroundMethodResultLiu, X., Reigle, J. K., Prasath, V. B. S., & Dhaliwal, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108093 · Cited by 18
Bas, T. G., & Duarte, V. (2024) · Pharmaceuticals · doi:10.3390/ph17070925 · Cited by 19
“In this sense, it collaborates in predictive modeling, helping researchers anticipate challenges and opportunities in the biosimilar development life cycle in record time [155].”
BackgroundImmunological Profiling of Paediatric Inflammatory Bowel Disease Using Unsupervised Machine Learning
Coelho, T. A. F., Mossotto, E., Gao, Y., Haggarty, R., Ashton, J. J., Batra, A., Stafford, I. S., Beattie, R. M., Williams, A. P., & Ennis, S. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002719 · Cited by 18
“It may be argued that given the complex polygenic nature of IBD and the resultant biological heterogeneity, the 2 conditions represent a phenotypic spectrum of an underlying immune dysregulation (29).”
BackgroundTheodorakopoulos, L., Theodoropoulou, A., & Halkiopoulos, C. (2025) · Electronics · doi:10.3390/electronics14193930 · Cited by 32
Schreiber, S., Irving, P. M., Sharara, A. I., Martín‐Arranz, M. D., Hébuterne, X., Penchev, P. I., Danese, S., Anthopoulos, P. L., Akhundova‐Unadkat, G., & Baert, F. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16781 · Cited by 17
Self-citationZhang, J., Zhang, X., Lu, M., Chang, Y., Wang, Q., Tu, J., Wu, H., Wang, C., Hong, Z., Xiong, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16050664 · Cited by 17
“To date, a host’s microbiome, genetics, and immune response are all accepted as essential risk factors for the development of UC [4], although the exact pathogenesis of UC is still an unanswered question.”
BackgroundKoutroumpakis, F., Phillips, A. E., Yadav, D. K., Machicado, J. D., Ahsan, M., Rivers, C. R., Tan, X., Schwartz, M. B., Proksell, S. S., Johnston, E. R., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa230 · Cited by 17
Sharma, D., Sharma, A., Singh, B., Kumar, S., & Verma, S. K. (2022) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.364003 · Cited by 16
Khafipour, A., Eissa, N., Munyaka, P. M., Rabbi, M. F., Kapoor, K., Kermarrec, L., Khafipour, E., Bernstein, C. N., & Ghia, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01405 · Cited by 19
“The prevalence of IBD has been increasing in industrialized countries; therefore, increasing medical costs mostly secondary to expensive biological therapies (Olivera et al., 2019).”
BackgroundBig Data in Gastroenterology Research
Alizadeh, M. A., Moura, N. S., Schledwitz, A., Patil, S. A., Ravel, J., & Raufman, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032458 · Cited by 17
“Imaging data X-ray, CT, MRI, endoscopy, capsule imaging data AI-based interpretation of upper, lower, and video capsule endoscopy can capture findings that may otherwise be overlooked Subjective interpretation by the operator is still required (relatively minor concern since these can be standardized) [14,15]”
BackgroundMystridis, G. A., Chatzopoulou, F. M., Patrinos, G. P., & Vizirianakis, I. S. (2022) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2022.06.003 · Cited by 16
Andretto, V., Rosso, A., Zilio, S., Sidi‐Boumedine, J., Boschetti, G., Sankar, S., Buffier, M., Miele, A. E., Denis, M., Choffour, P., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303280 · Cited by 16
A research agenda for GIScience in a time of disruptions
NELSON, T. A., Frazier, A. E., Kedron, P., Dodge, S., Zhao, B., Goodchild, M. F., Murray, A. T., Battersby, S. E., Bennett, L., Blanford, J. I., et al. (2024) · International Journal of Geographical Information Systems · doi:10.1080/13658816.2024.2405191 · Cited by 18
“Data access and computing often bears other costs, such as requiring connections at data producers (Olivera et al .”
Data Asset Quality Evaluation Framework Based on a Hybrid Multi‐Criteria Decision‐Making Method
Xu, T., You, X., Yang, M., Shi, Y., & Mao, R. (2024) · Quality and Reliability Engineering International · doi:10.1002/qre.3692 · Cited by 19
“While traditional dimensions such as accuracy, completeness, consistency, trustworthiness, and timeliness remain relevant, the inclusion of novel dimensions such as cost-effectiveness and profitability has become essential [17, 18].”
Honap, S., Danese, S., & Peyrin‐Biroulet, L. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae131 · Cited by 13
“27 While this can include structured as well as unstructured data, advances in natural language processing (NLP) may aid rapid data extraction from healthcare records.”
Self-citationArtificial intelligence in inflammatory bowel disease: current status and opportunities
Li, J., & Qian, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000714 · Cited by 13
“One study from Japan performed endocyto-scopy to evaluate the active histopathologic lesions using Chinese Medical Journal 2020;133(7) 91.0% in 187 UC patients and 22,853 images.”
InfluentialPregnancy zone protein, a potential research target in multiple diseases
Wu, Y., Zhao, Z., Deng, X., Jia, J., & Yuan, G. (2024) · Gene · doi:10.1016/j.gene.2024.149013 · Cited by 12
Popat, A., Saini, B., Patel, M., Seby, N., Patel, S., Harikrishnan, S., Shah, H. N. H., Pathak, P., Dekhne, A., Sen, U., et al. (2024) · Clinical Medicine & Research · doi:10.3121/cmr.2024.1934 · Cited by 12
“31 Recently, deep learning and neural networks have revolutionized medical imaging, significantly improving the accuracy of disease detection, including cancers and cardiovascular conditions.”
Schöler, D., Kostev, K., Peters, M., Zamfir, C., Wołk, A., Roderburg, C., & Loosen, S. H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154586 · Cited by 12
“However, as other working groups suggest [24,25], our study shows that in combination with big data, ML approaches can help improve the treatment of IBD patients in the future.”
ResultPhase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist
D’Amico, F., Baumann, C., Rousseau, H., Danese, S., & Peyrin‐Biroulet, L. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz214 · Cited by 11
Self-citationKoppelman, L. J. M., Oyugi, A. A., Maljaars, J., & Jong, A. E. V. D. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072296 · Cited by 10
“Despite their potential, large interpersonal variation among patients remains a challenge, emphasizing the need for personalization in model application and refinement [91,92].”
Luo, C., Tian, B., Zhou, Y., Luo, J., Shang, Q., Yu, S., Dai, M., Li, Y., & Chen, H. (2025) · Mediators of Inflammation · doi:10.1155/mi/4967641 · Cited by 9
“GM have been implicated in the pathophysiology of in fl ammation, especially in patients with con fi rmed IBD [3].”
Big data approach in the field of gastric and colorectal cancer research
Cheung, K. S. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16527 · Cited by 9
“6 Hence, a systematic connection or “ data fusion ” is vital to integrate the various datasets to provide meaningful insights and valuable perspectives in health data interpretation across multiple nations or regions.”
BackgroundFaecal Microbiota Microsphere Contributed to Relieving Gut Barrier Damage in Colitis
Zhen, S., Zhao, C., Zhao, X., Wu, J., & Li, J. (2020) · Macromolecular Research · doi:10.1007/s13233-020-8078-0 · Cited by 8
New Drugs in the Ulcerative Colitis Pipeline: Prometheus Unbound
Danese, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.12.011 · Cited by 8
Self-citationWang, J.-Y., Sun, M.-M., Liu, X., Yan, Q., Gao, Q., Ni, K.-Z., Yang, J.-Z., Zhang, S., Zhang, C.-Z., & Shan, C. (2024) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.167013 · Cited by 10
Sabhan, H., Bello, F., Muhsen, S., Borin, A., Johansson, F., Höög, C., Forsberg, O., Wennerström, C., Lördal, M., Almer, S. H., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002854 · Cited by 7
“A more generalizable knowledge of UST would be gained in a real-world setting with the important complement to the knowledge gained from the RCTs and to provide the necessary data needed in the drug application to support a fully comprehensive assessment [13,14].”
BackgroundParallel compression for large collections of genomes
Yao, H., Chen, S., Liu, S., Li, K., Ji, Y., Hu, G., & Wang, R. (2021) · Concurrency and Computation Practice and Experience · doi:10.1002/cpe.6339 · Cited by 7
Li, N., Wang, R., Li, W., Du, Q., Deng, Z., Fan, Y., & Zheng, L. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01559 · Cited by 7
Latuapon, E., Hochstenbach, L. M. J., Mahr, D., Scheenstra, B., Kietselaer, B., & Spreeuwenberg, M. D. (2023) · JMIR Human Factors · doi:10.2196/45006 · Cited by 8
“Previous research has found similar challenges; hence, these themes may represent common barriers in eHealth development [24-27].”
BackgroundJin, N., Liu, Y. Z., Xiong, P., Zhang, Y., Mo, J., Huang, X., & Zhou, Y. (2022) · Pharmaceuticals · doi:10.3390/ph15091038 · Cited by 6
“blood in the stool, and damage of the mucosal barrier [3,4].”
BackgroundTaida, T., Ohta, Y., Kato, J., Ogasawara, S., Ohyama, Y., Mamiya, Y., Nakazawa, H., Horio, R., Goto, C., Takahashi, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40624-5 · Cited by 6
“The application of data mining of patients with IBD has become a topic of great interest 16 .”
Rogers, C. C., Moutinho, T. J., Liu, X., & Valdez, R. S. (2021) · JMIR Human Factors · doi:10.2196/27452 · Cited by 6
Shahriari, A., Shams, S. A., Mahboobi, H., Yazdanparast, M. S., & Sarmadian, A. J. (2024) · Current Bioinformatics · doi:10.2174/0115748936302814240729062857 · Cited by 5
Innovative Strategies in Natural Product Drug Discovery: The Case of Anemoside B4
Kang, N., Zhao, J., Gao, P., Lu, Y., Chen, Z., Li, X., Khan, I. A., Yang, S., Xu, Q., & Liu, Y. (2025) · Engineering · doi:10.1016/j.eng.2025.06.036 · Cited by 5
Ahmad, N., Rodriguero, G. S., Zhu, Z.-S., Hao, Y., Yuxuan, S., & Pimentel, T. C. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105839 · Cited by 5
Mina, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0052 · Cited by 9
Applications of neural networks in liver transplantation
Meng, J., Liu, Z., & Xu, X. (2022) · iLiver · doi:10.1016/j.iliver.2022.07.002 · Cited by 5
“Medical big data include clinical trial registries, electronic medical records, medical images, and omics data [1].”
Therapeutic effect of indirubin-loaded bovine serum albumin nanoparticules on ulcerative colitis
Yu, G., Zhou, L., Liu, X., Liu, B., Lai, X., Xu, C.-L., Long, M.-Y., Zhu, Y.-M., Wang, J., & Li, M. (2022) · Biomaterials Science · doi:10.1039/d1bm01896e · Cited by 5
Data Analytics and Data Visualization for the Pharmaceutical Industry
Parikh, S., Patel, R. B., Khunt, D., Chavda, V. P., & Vora, L. K. (2023) · doi:10.1002/9781119865728.ch4 · Cited by 5
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases
Martin, M. B., Azkargorta, M., Lapitz, A., Moreno, L. O., Iloro, I., Fernández‐Tomé, S., Arbelaiz, A., Escobés, I., Marín, A. C., Bernardo, D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020526 · Cited by 4
Mina, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0014 · Cited by 4
Mohammadnia, N., Akyea, R. K., Qureshi, N., Bax, W. A., & Cornel, J. H. (2022) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztac059 · Cited by 4
Big data for neuroscience in the context of predictive, preventive, and personalized medicine
Bajinka, O., Ouédraogo, S. Y., Li, N., & Zhan, X. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00393-1 · Cited by 4
Applications of Blockchain Technologies in Health Services: A General Framework for Policymakers
Kara, O., & Kurutkan, M. N. (2021) · Accounting, finance, sustainability, governance & fraud · doi:10.1007/978-981-33-6811-8_11 · Cited by 4
Recent advances in self-regulated drug delivery devices
Wang, Y., Chen‐Mayfield, T., Li, Z., & Hu, Q. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89925-3.00012-5 · Cited by 4
Metadata
- Authors
- Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L.
- Affiliations
- Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
- IRCCS Humanitas Research Hospital (IT)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-01-18
- Volume
- 16
- Issue
- 5
- Pages
- 312-321
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2910890040
- Cited by
- 151
- References
- 149
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 28 · 2023: 14 · 2022: 32 · 2021: 27 · 2020: 18 · 2019: 10
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Social Sciences › Decision Sciences › Information Systems and Management › Big Data Technologies and Applications
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- big data, inflammatory bowel disease, predictive modeling, disease progression prediction, treatment response prediction, disease heterogeneity, drug safety, drug development, precision medicine, cost-effectiveness, electronic health records, clinical trial data, e-health applications, multi-omics data, microbiome data
- MeSH terms
- Clinical Decision-Making, Big Data, Cost-Benefit Analysis, Humans, Prognosis, United States, Inflammatory Bowel Diseases, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
